It was fabulous having the opportunity to see our Global Alliance members face to face again in 2022. After a number of years of waking at 1 am to join Video Meetings and hear what everyone was up to, it was great to be in the same room with many of our colleagues.
The ITP Impact Survey (I-WISh) is a collaborative investigation among global ITP experts, patient support groups and Novartis Pharmaceuticals Corporation.
The ITP Support Association held their 21st Annual Conference in the beautiful city of Chester, at the historic racecourse in the North West of England in October 2018. Here’s what they got up to.
While the PDSA held their first Regional Meeting in Australia in March 2018, they hold a conference annually in the USA bringing together carers and patients and providing new information on ITP through their growing network of medical advisors.
The interim results for the I-WISh survey undertaken by Novartis, which collaborated with 480 health care providers across 13 countries, found that a high percentage of patients with Immune Thrombocytopenia experienced negative impacts to their quality of life due to the immune disease.